Over at Chardan Capital, Geulah Livshits reiterated a buy rating and a $25 price target on July 23. From the stock's price of ...

Atai Life Sciences’ schizophrenia drug has failed to improve cognition in a phase 2 study, leading the biotech to reaffirm ...

Pop star-slash-psychedelic prince Harry Styles has been a sex symbol for the past decade, both as a member of boy-band ...

Oklahoma lawmakers say OKC’s new Thunder arena reflects the team’s commitment and signals a continued economic boost for the ...

KNW ("Know Labs" or the "Company"), a technology innovator specializing in non-invasive health monitoring solutions, today ...

Know Labs, Inc. (NYSE American: KNW) ("Know Labs" or the "Company"), a technology innovator specializing in non-invasive ...

For individuals considering cataract surgery in West Fargo, Vance Thompson Vision provides expert surgical care with a strong ...

On April 22, 2025, the U.S. Dept. of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) held a ...

Fifteen years after Greg left football, on the evening of May 21, 2024, The Ventura County Star published a news roundup ...

GOTHENBURG, SE / ACCESS Newswire / July 21, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announces that the first patient has been enrolled as part of the Continued Access ...

Biohaven Ltd., a New Haven-based bioscience firm, its chief executive officer and its chief financial officer are being sued ...

BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced ...